NFKB1 and Duchenne muscular dystrophy: They exhibit significant inhibitory effects on NF-κB activation in the model of LPS-induced acute lung injury (ALI) and the murine model of DMD (mdx mice), suggesting the potential of NBD mimetics to become a distinct class of anti-inflammatory drugs.